Today, despite the notable progress in diagnostics and therapeutics, cancer remains the second cause of death worldwide. This rather high mortality rate is often attributed to cancers diagnosed at late stages, including prostate cancer. Among the techniques approved for prostate cancer diagnosis, total or free prostate-specific antigen screening using blood serum samples is the sole method able to detect prostate cancer at an early stage. This test has led to a significant decrease in prostate cancer-related deaths. Nonetheless, it possesses several drawbacks, such as the complex, costly, and time-consuming conventional methods utilized in clinical laboratories to assess the concentration of...